Teniposide is not effective in chronic lymphocytic leukemia

V. Zagonel, U. Tirelli, A. Veronesi, E. Galligioni, S. Tumolo, M. Roncadin, A. Carbone, E. Grigoletto

Research output: Contribution to journalArticlepeer-review


Teniposide has been evaluated in a phase II clinical trial in chronic lymphocytic leukemia (CLL). Among 16 consecutive patients with CLL entered in the study and treated with Teniposide, 100 mg/m2 weekly, no objective response was observed. Toxicity was generally mild and mainly hematologic. Teniposide at this dosage and schedule is an inactive drug in CLL.

Original languageEnglish
Pages (from-to)59-61
Number of pages3
Issue number1
Publication statusPublished - Jan 1986


  • Chronic lymphocytic leukemia
  • Teniposide
  • VM-26

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Teniposide is not effective in chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Cite this